Top Analyst Reports for Bank of America, Chevron & Stryker
2025-04-14 22:15
https://finance.yahoo.com/news/top-analyst-reports-bank-america-211500618.html?.tsrc=rss

[<p class="tertiary yf-iko9m3 centerText">Oops, something went wrong</p>, <p class="modules-module_tipMessage__ZQFev">Tip: Try a valid symbol or a specific company name for relevant results</p>, <p class="tertiary yf-iko9m3 centerText">Oops, something went wrong</p>, <p class="notification-list-item-body yf-9621vi">Trump's trade war is unlikely to bring tech manufacturing back to the US anytime soon. Here's why.</p>, <p class="notification-list-item-body yf-9621vi">Dow slides 700 points, Nasdaq leads market rout as Powell warns of 'challenging' tariff impact</p>, <p class="notification-list-item-body yf-9621vi">The Nasdaq was down over 4% as a tech-led sell-off intensified in late-afternoon trading</p>, <p class="notification-list-item-body yf-9621vi">The major indexes sank to session lows as Fed Chair Powell warned of stagflationary impacts from President Trump's tariffs.</p>, <p class="notification-list-item-body yf-9621vi">Powell sees 'challenging scenario' for Fed if Trump tariffs stoke inflation and slow growth</p>, <p class="notification-list-item-body yf-9621vi">The Nasdaq fell over 2%, leading the way down as Nvidia found itself caught in the crossfire of the US-China trade war.</p>, <p class="notification-list-item-body yf-9621vi">The Treasury secretary told us he thinks America's biggest CEOs should stop worrying about the economy. Here's why.</p>, <p class="notification-list-item-body yf-9621vi">The chipmaker's stock took a hit after it revealed the Trump administration's surprise new controls on exports to China.</p>, <p class="notification-list-item-body yf-9621vi">Stocks resume slide as Nvidia weighs on tech</p>, <p class="notification-list-item-body yf-9621vi">Retail sales surged in March at the biggest rate in over two years, in what was the latest sign of the US economy's pre-tariff strength.</p>, <p class="notification-list-item-body yf-9621vi">Why your water bill is an inflation problem that isn't budging</p>, <p class="notification-list-item-body yf-9621vi">Stock market today: Dow, S&amp;P 500, Nasdaq futures fall as Nvidia reveals costly limits on China exports</p>, <p class="notification-list-item-body yf-9621vi">The Treasury secretary told Yahoo Finance that the next 90 days should provide 'substantial clarity' on tariffs</p>, <p class="notification-list-item-body yf-9621vi">Treasury Secretary Scott Bessent tells Yahoo Finance that the US has a 'big toolkit' to deal with bond market volatility</p>, <p class="notification-list-item-body yf-9621vi">Stocks drift lower as tariff chaos pauses for a day</p>, <p class="notification-list-item-body yf-9621vi">The chip giant committed to building AI infrastructure in the US, and Trump says he's going to help make it happen.</p>, <p class="notification-list-item-body yf-9621vi">The fallout from Trump's tariff whiplash hasn't yet pushed investors to shy away from an old habit</p>, <p class="notification-list-item-body yf-9621vi">Stocks edge higher after back-to-back rallies with Trump's latest tariff moves in focus</p>, <p class="notification-list-item-body yf-9621vi">BofA's Moynihan says 'we potentially face a changing economy' after highest-ever equities trading haul</p>, <p class="notification-list-item-body yf-9621vi">The trade war uncovers new economies of scale</p>, <p class="notification-list-item-body yf-9621vi">Trump is wrecking his own economic agenda</p>, <p class="notification-list-item-body yf-9621vi">Higher clothing costs from tariffs are coming soon — but not immediately, experts say</p>, <p class="notification-list-item-body yf-9621vi">Why Tesla, GM, and Rivian will be hurt most by China's critical minerals export ban</p>, <p class="notification-list-item-body yf-9621vi">Trump says he's 'looking at something' to help car companies with tariffs</p>, <p class="notification-list-item-body yf-9621vi">Stocks rally for second straight day, while Apple jumps on tech tariff reprieve</p>, <p class="notification-list-item-body yf-9621vi">The Nasdaq briefly turned red as stocks' relief rally failed to hold in early afternoon trading</p>, <p class="notification-list-item-body yf-9621vi">Americans are braced for the biggest unemployment rate jump since the pandemic, a New York Fed survey found</p>, <p class="notification-list-item-body yf-9621vi">Stocks surge as Apple leads way higher after tech's tariff reprieve</p>, <p class="notification-list-item-body yf-9621vi">Trump's temporary tech tariff respite adds to a growing sense that he has a willingness to listen and bend</p>, <p class="notification-list-item-body yf-9621vi">Goldman CEO Solomon warns of 'markedly different operating environment' as dealmaking slows</p>, <p class="notification-list-item-body yf-9621vi">Corporate earnings take center stage amid tariff turmoil: What to know this week</p>, <p class="notification-list-item-body yf-9621vi">Trump has tariffs, taxes, and the debt ceiling on a collision course for this summer</p>, <p class="notification-list-item-body yf-9621vi">Trump denies that there was a tariff “exception” for certain electronics announced Friday. (Bloomberg)</p>, <p class="notification-list-item-body yf-9621vi">Tax day 2025 is coming up. Here’s what to know to file by the deadline.</p>, <p class="notification-list-item-body yf-9621vi">Commentary: Put the P/E ratio in timeout for now</p>, <p class="notification-list-item-body yf-9621vi">Market chaos signals 'sell America' trade as Trump tariff whipsaw threatens to upend the US economy's soft landing</p>, <p class="notification-list-item-body yf-9621vi">Apple was on brink of crisis before tariff concession from Trump (Bloomberg)</p>, <p class="notification-list-item-body yf-9621vi">Corporate earnings take center stage amid tariff turmoil: What to know this week</p>, <p class="notification-list-item-body yf-9621vi">The best (and worst) time of year to buy a house</p>, <p class="notification-list-item-body yf-9621vi">The Trump family is going all-in on crypto projects, from Bitcoin mining to stablecoins (Bloomberg)</p>, <p class="notification-list-item-body yf-9621vi">How to invest in gold in 4 steps</p>, <p class="notification-list-item-body yf-9621vi">Changing jobs can disrupt saving for retirement. Here's how to stay on track.</p>, <p class="notification-list-item-body yf-9621vi">Trump exempts phones, computers, chips from ‘reciprocal’ tariffs (Bloomberg)</p>, <p class="notification-list-item-body yf-9621vi">Meet Walmart heir Steuart Walton, the most powerful board member you’ve never heard of</p>, <p class="notification-list-item-body yf-9621vi">The tariff uncertainty isn't getting any better in markets: Chart of the Week</p>, <p class="notification-list-item-body yf-9621vi">'T-shirts could be the new eggs': Why Trump's chaotic tariff whipsaw is still a huge threat to inflation</p>, <p class="notification-list-item-body yf-9621vi">Gold notches best week since 2020 amid 'shaken' investor confidence in US</p>, <p class="notification-list-item-body yf-9621vi">The bond market just had one of its most volatile and unusual weeks in recent memory</p>, <p class="notification-list-item-body yf-9621vi">Stocks capped a wild week with a surge higher, as the S&amp;P 500 posted its biggest weekly gain since 2023</p>, <p class="notification-list-item-body yf-9621vi">Stocks swung into rally mode in afternoon trading, with the major indexes all up over 1%. Bond yields pared bigger gains.</p>, <p class="type-body-sm-med yf-rtg296">Unlock stock picks and a broker-level newsfeed that powers Wall Street.</p>, <p class="yf-1090901"><span><strong>Monday, April 14, 2025</strong><br/><br/>The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corporation (BAC), Chevron Corporation (CVX) and Stryker Corporation (SYK), as well as two micro-cap stocks Value Line, Inc. (VALU) and Sypris Solutions, Inc. (SYPR). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.<br/><br/>These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.<br/><br/>You can <strong>see all of today’s research reports here &gt;&gt;&gt;</strong><br/><br/><strong>Today's Featured Research Reports</strong><br/><br/>Shares of <strong>Bank of America</strong> have gained +2.5% over the past year against the Zacks Financial - Investment Bank industry’s gain of +20.4%. The company’s volatile nature of the trading business is a major headwind. Despite an impressive performance since 2022, it is expected to normalize going forward. This is likely to hamper fee income growth. <br/><br/>The Zacks analyst project non-interest income to rise only 3.4% in 2025. Continued investments in the franchise will keep the company’s expenses elevated. We expect total non-interest expenses to rise 3% this year. While high funding costs are still a woe, the company’s net interest income (NII) will be positively impacted by higher rates for longer. <br/><br/>The Zacks analyst expects NII to record a CAGR of 5.3% over the next three years. Plans to open financial centers in new and existing markets and improve digital capabilities will aid the top line. We project total revenues to grow 4.8% in 2025.<br/><br/>(You can <strong>read the full research report on Bank of America here &gt;&gt;&gt;</strong>)<br/><br/><strong>Chevron’s</strong> shares have declined -6.2% over the past six months against the Zacks Oil and Gas - Integrated - International industry’s decline of -11.9%. The company being a fully integrated energy firm, is positioned as one of the top global integrated oil firms, set for sustainable production growth, particularly due to its dominant position in the lucrative Permian Basin. <br/><br/>Further, the planned acquisition of Hess Corporation is expected to significantly strengthen Chevron's presence in oil-rich Guyana. However, the company is grappling with high sensitivity to oil fluctuations and relatively expensive valuation. <br/><br/>Another concern is the weak margins on refined products that forced its downstream segment to its first quarterly loss in 4 years. Considering these factors, investors are advised to wait for a better entry point.<br/><br/>(You can <strong>read the full research report on Chevron here &gt;&gt;&gt;</strong>)<br/><br/>Shares of <strong>Stryker</strong> have gained +4.3% over the past year against the Zacks Medical - Products industry’s gain of +5.5%. The company is poised for growth, driven by rising demand for robotic-assisted procedures, hospital capital expenditures and international expansion. The Mako SmartRobotics platform fuels adoption, while acquisitions like Inari Medical and Vertos Medical enhance the portfolio. <br/><br/>Stryker is actively integrating new technologies such as AI-driven imaging and smart surgical systems to improve patient outcomes and maintain its competitive edge. Pricing improvements and a strong hospital order book support 2025 growth. <br/><br/>However, foreign exchange volatility and acquisition-related margin pressures may impact earnings. Supply chain disruptions and rising costs could strain profitability. Intensifying competition in robotics and MedTech demands constant innovation. Macroeconomic risks, including potential downturns in healthcare spending and regulatory shifts, add uncertainty.<br/><br/>(You can <strong>read the full research report on Stryker here &gt;&gt;&gt;</strong>)<br/><br/><strong>Value Line’s</strong> shares have outperformed the Zacks Financial - Investment Management industry over the past year (+10% vs. +6.4%). This microcap company with market capitalization of $370.23 million have robust cash generation, with cash balances rising to $27.1 million from $6.1 million YoY, enhances liquidity and supports dividends, buybacks, and growth investments. EAM Trust income surged 47.7% to $13.8 million, driven by AUM growth to $5 billion, providing a rising, diversified passive income stream. <br/><br/>The company maintains disciplined capital returns, paying $0.90/share in dividends and repurchasing shares, with $0.9 million authorization remaining. Portfolio gains doubled to $3.6 million, bolstering earnings. Strong branding and diversified offerings serve both retail and institutional clients, supporting market position. <br/><br/>However, core publishing revenue declined to $26.7 million, and customer concentration (30% from one client) heightens risk. Operating costs and taxes rose, further pressuring margins, while limited international presence (~2% of revenues) increases vulnerability to U.S. market shifts.<br/><br/>(You can <strong>read the full research report on Value Line here &gt;&gt;&gt;</strong>)<br/><br/>Shares of <strong>Sypris Solutions</strong> have gained +3.6% over the past year against the Zacks Electronics - Miscellaneous Services industry’s gain of +36.3%. This microcap company with market capitalization of $36.37 million benefits from an extended long-term supply agreement with a global OEM, securing stable revenues as a sole-source supplier of Ultra Axle Shafts. <br/><br/>Sypris Solutions’ diversified presence across automotive, energy, and industrial markets reduces risk and positions it to capitalize on growth trends in heavy-duty vehicles and energy infrastructure. Sypris Solutions is also aligned with growth in aerospace and defense electronics, leveraging its capabilities in high-precision components to meet rising demand. Expansion into the Asia-Pacific region aligns with high-growth markets, leveraging regional investments in defense and infrastructure. <br/><br/>However, liquidity challenges constrain financial flexibility. Rising costs and reliance on cyclical markets such as heavy vehicles and oil and gas exacerbate margin sensitivity. Competitive pressures in aerospace further heighten vulnerability.<br/><br/>(You can <strong>read the full research report on Sypris Solutions here &gt;&gt;&gt;</strong>)<br/><br/>Other noteworthy reports we are featuring today include Pfizer Inc. (PFE), Ormat Technologies, Inc. (ORA) and ONEOK, Inc. (OKE).<br/><br/>Director of Research<br/><br/>Sheraz Mian<br/><br/><em>Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly <strong>Earnings Trends</strong> and <strong>Earnings Preview</strong> reports. If you want an email notification each time Sheraz publishes a new article, please <strong>click here&gt;&gt;&gt;</strong></em></span></p>, <p class="yf-1090901"><b>Today's Must Read</b></p>, <p class="yf-1090901">Branch Openings, High Rates Aid BofA (BAC), Fee Income Ails<br/></p>, <p class="yf-1090901">Permian Strength Supports Chevron's (CVX) Production Growth<br/></p>, <p class="yf-1090901">Diversified Product Portfolio Drives Stryker's (SYK) Prospects<br/></p>, <p class="yf-1090901"><b>Featured Reports</b></p>, <p class="yf-1090901">Pfizer's (PFE) New Products Can Drive Sales Growth in 2025<br/>Pfizer's non-COVID revenues improved in 2024, driven by its key drugs like Vyndaqel, new launches and newly acquired products from Seagen. The trend should continue in 2025, per the Zacks analyst.</p>, <p class="yf-1090901">Investments Aid Ormat (ORA), Weak Solvency Pose Threat<br/>Per the Zacks analyst, Ormat Technologies' investment in enhancing manufacturing capacity should boost growth. Yet, its weak solvency position threatens the stock's ability to pay off its debt.</p>, <p class="yf-1090901">Midstream Assets &amp; Higher Fee-Based Earnings Aid ONEOK (OKE)<br/>Per the Zacks analyst, ONEOK is set to benefit from fee-based earnings and midstream assets located in productive regions. Investments made to expand pipelines will drive its performance.</p>, <p class="yf-1090901">Broadridge (BR) Gains From Itiviti Buyout, Competition High<br/>Per the Zacks analyst, the Itiviti acquisition has boosted Broadridge's global technology and operations segment. High competition from other players is an overhang.</p>, <p class="yf-1090901">Acquisition of Edmunds Aids CarMax (KMX), High Debt Ails<br/>Per the Zacks analyst, the acquisition of Edmunds has bolstered CarMax's position in the used auto market. However, its high long-term debt-to-capital ratio remains a concern.</p>, <p class="yf-1090901">Watts Water (WTS) Gains on Acquisitions Amid Europe Weakness<br/>Per the Zacks analyst, Watts Water gains from solid acquisitions, cost-cutting efforts and a strong balance sheet, though fewer shipping days and Europe weakness remain concerns.</p>, <p class="yf-1090901">Solid Unit Expansion Aid Choice Hotels (CHH), Macro Woes Ail<br/>Per the Zacks analyst, Choice Hotels benefits from its unit growth strategy, hotel conversions and franchise business. However, uncertain macroeconomic environments are a concern.</p>, <p class="yf-1090901"><b>New Upgrades</b></p>, <p class="yf-1090901">Starz Subscriber Growth Aids Lionsgate's (LGF.A) Prospects<br/>Per the Zacks analyst, increased premium programming, along with higher Starz subscriber growth, is likely to aid Lionsgate's top line growth.</p>, <p class="yf-1090901">EverQuote (EVER) Boasts Revenue Growth, Solid Balance Sheet<br/>Per the Zacks analyst, consumer traffic, quote request volume and innovative advertiser products and services drive EverQuote revenues. Its strong balance sheet enables it to fulfill debt obligations.</p>, <p class="yf-1090901">Acquisition of Nissens Boosts Standard Motor (SMP) Prospects<br/>Per the Zacks analyst, the buyout of Nissens has helped Standard Motor expand its geographic presence and establish a significant global growth platform, which will boost its top-line growth in 2025.</p>, <p class="yf-1090901"><b>New Downgrades</b></p>, <p class="yf-1090901">Campbell's (CPB) Gross Margins Hurt by Cost Inflation<br/>Per the Zacks analyst, cost inflation hurt Campbell's gross margin. In the second quarter fiscal 2025, adjusted gross profit margin fell 100 basis points, hit by cost inflation and supply-chain costs.</p>, <p class="yf-1090901">Rising Expenses, Low Liquidity Hurt Carlyle's (CG) Growth<br/>Per the Zacks analyst, Carlyle's rising cost base will likely hurt bottom-line growth. Also, with limited liquidity, the company might not be able to meet its near-term debt obligations.</p>, <p class="yf-1090901">Macroeconomic Pressures, Fierce Rivalry Ails Illumina (ILMN)<br/>The Zacks analyst is concerned with Illumina's robust market opportunity in China taking a hit after MOFCOM bans imports of its NGS sequencers. Intense competitive landscape adds to the worry.</p>, <p class="yf-1090901">Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. <a class="link" data-rapid_p="18" data-ylk="slk:Click to get this free report;elm:context_link;itc:0;sec:content-canvas" href="https://www.zacks.com/registration/pfp/?ALERT=RPT_7BEST_YHOSYND&amp;ADID=SYND_YAHOO_7BEST_RESEARCHDAILY_2448509&amp;cid=CS-YAHOO-FT-research_daily-2448509&amp;t=BAC" rel="nofollow noopener" target="_blank">Click to get this free report</a></p>, <p class="yf-1090901"><a class="link" data-rapid_p="19" data-ylk="slk:Bank of America Corporation (BAC) : Free Stock Analysis Report;elm:context_link;itc:0;sec:content-canvas" href="https://www.zacks.com/registration/pfp?ALERT=YAHOO_ZER&amp;d_alert=ZER_CONF&amp;t=BAC&amp;ADID=SYND_YAHOO_TCK_RESEARCHDAILY_2448509_BAC&amp;cid=CS-YAHOO-FT-research_daily-2448509" rel="nofollow noopener" target="_blank">Bank of America Corporation (BAC) : Free Stock Analysis Report</a></p>, <p class="yf-1090901"><a class="link" data-rapid_p="20" data-ylk="slk:Chevron Corporation (CVX) : Free Stock Analysis Report;elm:context_link;itc:0;sec:content-canvas" href="https://www.zacks.com/registration/pfp?ALERT=YAHOO_ZER&amp;d_alert=ZER_CONF&amp;t=CVX&amp;ADID=SYND_YAHOO_TCK_RESEARCHDAILY_2448509_CVX&amp;cid=CS-YAHOO-FT-research_daily-2448509" rel="nofollow noopener" target="_blank">Chevron Corporation (CVX) : Free Stock Analysis Report</a></p>, <p class="yf-1090901"><a class="link" data-rapid_p="21" data-ylk="slk:Pfizer Inc. (PFE) : Free Stock Analysis Report;elm:context_link;itc:0;sec:content-canvas" href="https://www.zacks.com/registration/pfp?ALERT=YAHOO_ZER&amp;d_alert=ZER_CONF&amp;t=PFE&amp;ADID=SYND_YAHOO_TCK_RESEARCHDAILY_2448509_PFE&amp;cid=CS-YAHOO-FT-research_daily-2448509" rel="nofollow noopener" target="_blank">Pfizer Inc. (PFE) : Free Stock Analysis Report</a></p>, <p class="yf-1090901"><a class="link" data-rapid_p="22" data-ylk="slk:Stryker Corporation (SYK) : Free Stock Analysis Report;elm:context_link;itc:0;sec:content-canvas" href="https://www.zacks.com/registration/pfp?ALERT=YAHOO_ZER&amp;d_alert=ZER_CONF&amp;t=SYK&amp;ADID=SYND_YAHOO_TCK_RESEARCHDAILY_2448509_SYK&amp;cid=CS-YAHOO-FT-research_daily-2448509" rel="nofollow noopener" target="_blank">Stryker Corporation (SYK) : Free Stock Analysis Report</a></p>, <p class="yf-1090901"><a class="link" data-rapid_p="23" data-ylk="slk:ONEOK, Inc. (OKE) : Free Stock Analysis Report;elm:context_link;itc:0;sec:content-canvas" href="https://www.zacks.com/registration/pfp?ALERT=YAHOO_ZER&amp;d_alert=ZER_CONF&amp;t=OKE&amp;ADID=SYND_YAHOO_TCK_RESEARCHDAILY_2448509_OKE&amp;cid=CS-YAHOO-FT-research_daily-2448509" rel="nofollow noopener" target="_blank">ONEOK, Inc. (OKE) : Free Stock Analysis Report</a></p>, <p class="yf-1090901"><a class="link" data-rapid_p="24" data-ylk="slk:Ormat Technologies, Inc. (ORA) : Free Stock Analysis Report;elm:context_link;itc:0;sec:content-canvas" href="https://www.zacks.com/registration/pfp?ALERT=YAHOO_ZER&amp;d_alert=ZER_CONF&amp;t=ORA&amp;ADID=SYND_YAHOO_TCK_RESEARCHDAILY_2448509_ORA&amp;cid=CS-YAHOO-FT-research_daily-2448509" rel="nofollow noopener" target="_blank">Ormat Technologies, Inc. (ORA) : Free Stock Analysis Report</a></p>, <p class="yf-1090901"><a class="link" data-rapid_p="25" data-ylk="slk:Sypris Solutions, Inc. (SYPR) : Free Stock Analysis Report;elm:context_link;itc:0;sec:content-canvas" href="https://www.zacks.com/registration/pfp?ALERT=TCK_MC_SYND&amp;d_alert=rd_final_rank&amp;t=SYPR&amp;ADID=SYND_YAHOO_TCK_RESEARCHDAILY_2448509_SYPR&amp;cid=CS-YAHOO-FT-research_daily-2448509" rel="nofollow noopener" target="_blank">Sypris Solutions, Inc. (SYPR) : Free Stock Analysis Report</a></p>, <p class="yf-1090901"><a class="link" data-rapid_p="26" data-ylk="slk:Value Line, Inc. (VALU): Free Stock Analysis Report;elm:context_link;itc:0;sec:content-canvas" href="https://www.zacks.com/registration/pfp?ALERT=TCK_MC_SYND&amp;d_alert=ZER_CONF&amp;t=VALU&amp;ADID=SYND_YAHOO_TCK_RESEARCHDAILY_2448509_VALU&amp;cid=CS-YAHOO-FT-research_daily-2448509" rel="nofollow noopener" target="_blank">Value Line, Inc. (VALU): Free Stock Analysis Report</a></p>, <p class="yf-1090901"><a class="link" data-rapid_p="27" data-ylk="slk:This article originally published on Zacks Investment Research (zacks.com).;elm:context_link;itc:0;sec:content-canvas" href="https://www.zacks.com/commentary/2448509/top-analyst-reports-for-bank-of-america-chevron-stryker?cid=CS-YAHOO-FT-research_daily-2448509&amp;t=BAC" rel="nofollow noopener" target="_blank">This article originally published on Zacks Investment Research (zacks.com).</a></p>, <p class="yf-1090901"><a class="link" data-rapid_p="28" data-ylk="slk:Zacks Investment Research;elm:context_link;itc:0;sec:content-canvas" href="https://www.zacks.com/?t=BAC&amp;cid=CS-YAHOO-FT-research_daily-2448509" rel="nofollow noopener" target="_blank">Zacks Investment Research</a></p>, <p class="clamp yf-1y7058a">Merck and AbbVie are included in this Analyst Blog.</p>, <p class="clamp yf-1y7058a">We recently published a list of Jim Cramer Sounds the Alarm on China Rhetoric and Dollar Panic Then Analyzes 11 Key Stocks. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against other key stocks that Jim Cramer analyzes. In his latest appearance on CNBC’s Squawk on the […]</p>, <p class="clamp yf-1y7058a">Caterpillar (CAT) on Tuesday named Joseph Creed as the company's next chief executive, succeeding D.</p>, <p class="clamp yf-1y7058a">HAL and Nabors' collaboration in Oman delivers first automated drilling solutions, improving operational efficiency, penetration rates and reducing non-productive time.</p>, <p class="clamp yf-1y7058a">CVS Health and UnitedHealth are two of the top companies leading the S&amp;P 500 chart YTD. But which is the better investment now? Let's take a closer look.</p>, <p class="clamp yf-1y7058a">Bank of America, Chevron, Stryker, Value Line and Sypris are included in this Analyst Blog.</p>, <p class="clamp yf-1y7058a">Shares of Novo Nordisk, Eli Lilly, Structure Therapeutics and Viking Therapeutics gain as PFE abandons development of its obesity candidate, danuglipron, due to safety issues.</p>, <p class="clamp yf-1y7058a">Shares of Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are on the rise on Monday after Pfizer (PFE) announced its decision to discontinue development of danuglipron, an oral glucagon-like peptide-1 receptor agonist, which was being investigated for chronic weight management. While Morgan Stanley predicts “limited reaction” in Pfizer’s shares following the news, JPMorgan tells investors that the decision is “mostly a positive” for Structure and Viking, both developing drugs in the</p>, <p class="clamp yf-1y7058a">We recently published a list of Biotech Stocks Dominate Monday’s Top 10 Gainers. In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other biotech stocks that dominate Monday’s top gainers. The stock market kicked off the shortened trading week on a positive note, with Wall Street’s major […]</p>, <p class="clamp yf-1y7058a">(Bloomberg) -- Supply Lines is a daily newsletter that tracks global trade. Sign up here.Most Read from BloombergHow Did This Suburb Figure Out Mass Transit?The Secret Formula for Faster TrainsEven Oslo Has an Air Quality ProblemNYC Tourist Helicopter Crashes in Hudson River, Killing SixLisbon Mayor Wants Companies to Help Fix City’s Housing ShortagePresident Donald Trump’s administration pressed forward with plans to impose tariffs on semiconductor and pharmaceutical imports by initiating trade</p>, <p class="modules-module_tipMessage__ZQFev">Tip: Try a valid symbol or a specific company name for relevant results</p>, <p class="redirectMsg">Sign in to access your portfolio</p>, <p>
<span class="spcht" id="spcht"></span>
<span></span>
<span class="spcht" id="spcht-retry">Try again.</span>
</p>]